Literature DB >> 2456789

Isoproterenol-induced desensitization of mucin release in isolated rat submandibular acini.

N A Bradbury1, M A McPherson.   

Abstract

Release of [14C]glucosamine-labelled mucins was studied in vitro using well-characterised preparations of rat submandibular acini. Mucin release was stimulated by forskolin, an activator of the catalytic subunit of adenylate cyclase, and 3-isobutyl-1-methylxanthine (IBMX), a cyclic nucleotide phosphodiesterase inhibitor. Both stimulated in a dose-dependent manner to the same maximum as that seen with isoproterenol. Neither forskolin nor IBMX added in the presence of isoproterenol increased secretion above the maximum in response to isoproterenol alone, suggesting a similar mechanism of action, mediated by cyclic AMP. Prior exposure of acini to isoproterenol (10 microM) for 45 min, followed by washout resulted in (a) persistent increase in basal secretion which was abolished by propranolol and (b) reduced stimulation of mucin secretion in response to either a second isoproterenol challenge, noradrenaline or forskolin. Thus, exposure of rat submandibular acini in vitro desensitizes the cells to subsequent stimulation. Although this mimics the decreased beta-adrenergic secretory responses seen in submandibular cells from cystic fibrosis patients, results suggest that the isoproterenol-induced desensitization is at the level of beta-receptor and adenylate cyclase, rather than distal to cyclic AMP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456789     DOI: 10.1016/0167-4889(88)90136-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Beta-adrenergic mobilization of Ca2+ from an intracellular store in rat submandibular acini.

Authors:  C Lloyd Mills; M B Hallett; M A McPherson; R L Dormer
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

2.  Cyclic AMP-independent secretion of mucin by SW1116 human colon carcinoma cells. Differential control by Ca2+ ionophore A23187 and arachidonic acid.

Authors:  S Yedgar; O Eidelman; E Malden; D Roberts; R Etcheberrigaray; G Goping; C Fox; H B Pollard
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

3.  Evidence against resveratrol as a viable therapy for the rescue of defective ΔF508 CFTR.

Authors:  Ying Jai; Kalpit Shah; Robert J Bridges; Neil A Bradbury
Journal:  Biochim Biophys Acta       Date:  2015-09-02

4.  Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis.

Authors:  Isha Dey; Kalpit Shah; Neil A Bradbury
Journal:  J Genet Syndr Gene Ther       Date:  2016-01-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.